Purchase Order 36C26025P0684
Award Date
5/1/25
Potential Completion Date
10/30/25
Potential Value
$300K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Orlando, FL 32824, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) has awarded a $49,950 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract is for the emergency delivery of 84 tablets of Impavido (Miltefosine) in three packages of 28, to the VA's Oklahoma City VA Medical Center (OKCVAMC) Pharmacy. This purchase order is part of a larger Blanket Purchase Agreement (BPA) valued at $1,127,000 that Profounda Inc. holds...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $33,300.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract has an ultimate completion date of January 8, 2025. Profounda Inc. has a significant Blanket Purchase Agreement...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business. The $49,950.00 contract is for the delivery of Profounda's Impavido/Miltefosine pharmaceutical product to the VA Sunshine Healthcare Network (VISN 20) in Orlando, Florida. Impavido/Miltefosine is used to treat leishmaniasis and other drug-resistant infections in veterans. This award is the latest in a...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $144,000.00 firm fixed-price purchase order is for the delivery of Impavido/Miltefosine, a specialized medication used to treat leishmaniasis and other drug-resistant infections in veterans. Profounda Inc. has received numerous similar purchase orders from various Veterans Integrated...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $96,000.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. Profounda Inc. has a...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer. The $116,550 contract is for the delivery of Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections in veterans. The contract has an ultimate completion date of September 30, 2024 and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA)...
The U.S. Department of Veterans Affairs (VA) awarded a $1,000,000.00 Firm Fixed Price Purchase Order to Annovex Pharma Inc., a Self Certified Small Disadvantaged Business, for the delivery of Dosed Anesthesia Medications. The contract, which has no set-aside designation, will have a performance period ending on July 31, 2026. The award was made on August 1, 2024 under the Veterans Integrated Service Network 5 (VISN 5) program, which is a civilian agency focused on healthcare services for...
This federal contract award is for the procurement of IDOSE TR 75MCG IMPLANT TRADE medical devices by the U.S. Department of Veterans Affairs (VA). The prime contractor is Avedro, Inc., a subsidiary of Glaukos Corporation, a for-profit medical device manufacturer specializing in ophthalmic products. The contract is a firm-fixed-price delivery order with a ceiling value of $21,310.56 and an ultimate completion date of January 31, 2026. This award is not associated with a set-aside designation,...